NCT03698682View on ClinicalTrials.gov

Short Compared With Standard Duration of Antibiotic Treatment for AECOPD

PHASE2CompletedINTERVENTIONAL
Enrollment

310

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Levofloxacin 500mg

One tablet per day for 7 days.

Trial Locations (1)

5000

Emergency department of university hospital Fattouma Bourguiba of Monastir, Monastir

All Listed Sponsors
lead

University of Monastir

OTHER

NCT03698682 - Short Compared With Standard Duration of Antibiotic Treatment for AECOPD | Biotech Hunter | Biotech Hunter